Sort

Search

01/01/2022 Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network
de Mendoza C., Pérez L., Fernández-Ruiz M., Pena M.J., Ramos J.M., Richart A., Piron M., Rando A., Miró E., Reina G., Encinas B., Rojo S., Rodriguez-Iglesias A.M., Benito R., Aguilera A., Treviño A., Corral O., Soriano V.. Late presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategies: on behalf of the Human T-lymphotropic Virus (HTLV) Spanish Network. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2022; 122DOI:10.1016/j.ijid.2022.07.043. PMID:35902023. IF:8.400(Q1/2D).
01/01/2022 Corrigendum to “Prognosis of unexpected positive intraoperative cultures in arthroplasty revision: A large multicenter cohort” [Journal of Infection 83 (2021) 542–549] (Journal of Infection (2021) 83(5) (542–549), (S0163445321004527), (10.1016/j.jinf.2021.09.001))
Mancheño-Losa M., Lora-Tamayo J., Fernández-Sampedro M., Rodríguez-Pardo D., Muñoz-Mahamud E., Soldevila L., Palou M., Barbero J.M., del Toro M.D., Iribarren J.A., Benito N., Sobrino B., Rico-Nieto A., Guío-Carrión L., Gómez L., Escudero-Sánchez R., García-País M.J., Jover-Sáenz A., Praena J., Baraia-Etxaburu J.M., Auñón Á., Múñez-Rubio E., Murillo O.. Corrigendum to “Prognosis of unexpected positive intraoperative cultures in arthroplasty revision: A large multicenter cohort” [Journal of Infection 83 (2021) 542–549] (Journal of Infection (2021) 83(5) (542–549), (S0163445321004527), (10.1016/j.jinf.2021.09.001)). JOURNAL OF INFECTION. 2022; 84(5)DOI:10.1016/j.jinf.2022.01.021. PMID:35105460. IF:(Q/D).
01/01/2022 Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial
Sojo-Dorado J., López-Hernández I., Rosso-Fernandez C., Morales I.M., Palacios-Baena Z.R., Hernández-Torres A., Merino De Lucas E., Escolà-Vergé L., Bereciartua E., García-Vázquez E., Pintado V., Boix-Palop L., Natera-Kindelán C., Sorlí L., Borrell N., Giner-Oncina L., Amador-Prous C., Shaw E., Jover-Saenz A., Molina J., Martínez-Alvarez R.M., Dueñas C.J., Calvo-Montes J., Silva J.T., Cárdenes M.A., Lecuona M., Pomar V., Valiente De Santis L., Yagüe-Guirao G., Lobo-Acosta M.A., Merino-Bohórquez V., Pascual A., Rodríguez-Baño J.. Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial. JAMA Network Open. 2022; 5(1)DOI:10.1001/jamanetworkopen.2021.37277. PMID:35024838. IF:13.800(Q1/1D).
01/01/2022 Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis
Tornero-Molina, J, Alperi-Lopez, M, Castellvi, I, de Agustin-de Oro, JJ, Escudero, A, Garcia-Vicuna, R, Gonzalez-Gay, MA, Hidalgo, C, Rubio, E, Sanmarti, R, Casamira, N, Calvo-Alen, J. Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis. Reumatologia Clinica. 2022; 18(1)DOI:10.1016/j.reuma.2020.08.003. PMID:35090610. IF:(Q/D).